These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19018866)

  • 1. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
    Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
    Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome.
    Qian J; Yao DM; Lin J; Wang YL; Han LX; Xu WR; Wu CY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):74-81. PubMed ID: 19196380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of death-associated protein kinase 1 CpG islands in myelodysplastic syndromes.
    Wu X; Liu W; Tian Y; Xiao M; Wu Y; Li C
    Acta Haematol; 2011; 125(4):179-85. PubMed ID: 21212658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
    Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
    Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
    Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAPK1 promoter hypermethylaiton in brain metastases and peripheral blood.
    Martinez-Glez V; Franco-Hernandez C; Gonzalez-Gomez P; Isla A; De Campos JM; Vaquero J; Gutierrez M; Casartelli C; Rey JA
    Neoplasma; 2007; 54(2):123-6. PubMed ID: 17319784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].
    Nakatsuka S; Takakuwa T; Aozasa K
    Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of PRAME gene in chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Jose-Eneriz ES; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
    Leuk Res; 2007 Nov; 31(11):1521-8. PubMed ID: 17382387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
    Amin HM; Hoshino K; Yang H; Lin Q; Lai R; Garcia-Manero G
    J Pathol; 2007 Aug; 212(4):402-10. PubMed ID: 17503411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
    Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
    Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
    Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
    Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methylation status of id4 gene promoter in patients with chronic myeloid leukemia].
    Wang XR; Kang HY; Cen J; Li YH; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1402-4. PubMed ID: 21176338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between blast crisis of chronic myeloid leukemias and abnormality of p16 and calcitonin genes].
    Xu D; Hong W; Wang S
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):151-3. PubMed ID: 11776646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation status of CEBPA gene promoter in chronic myeloid leukemia.
    Annamaneni S; Kagita S; Gorre M; Digumarti RR; Satti V; Battini MR
    Hematology; 2014 Jan; 19(1):42-4. PubMed ID: 23541085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa.
    Roman-Gomez J; Castillejo JA; Jimenez A; Cervantes F; Boque C; Hermosin L; Leon A; Grañena A; Colomer D; Heiniger A; Torres A
    J Clin Oncol; 2003 Apr; 21(8):1472-9. PubMed ID: 12697869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
    Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
    Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
    Leuk Res; 2008 Mar; 32(3):487-90. PubMed ID: 17765966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].
    Tan B; Cao P; Qi Z
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):371-3. PubMed ID: 12080652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.